SCHEMBL4723282

SCHEMBL4723282

CS(=O)(=O)C(CCn1ccc2ncnc(Nc3ccc(Oc4cccc(C5(C#N)CC5)c4)c(Cl)c3)c21)C(N)=O

nearest known ligand 0.60

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.60
ERBB2 P04626 20/20 0.60
ERBB4 Q15303 10/20 0.55
ERBB3 P21860 9/20 0.55
LCK P06239 1/20 0.53
LYN P07948 1/20 0.53
MET P08581 1/20 0.53
CSK P41240 1/20 0.53
MAP2K1 Q02750 1/20 0.53
AURKB Q96GD4 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3508119 0.86 EGFR (0.79) EGFRERBB2ERBB4ERBB3LCK
Hydrochloric Acid SCHEMBL3504260 0.86 EGFR (0.78) EGFRERBB2ERBB4ERBB3LCK
Hydrochloric Acid SCHEMBL3505403 0.85 EGFR (0.62) EGFRERBB2ERBB4ERBB3
SCHEMBL3507457 0.82 EGFR (0.60) EGFRERBB2ERBB4ERBB3LCK
SCHEMBL13226167 0.79 EGFR (0.67) EGFRERBB2ERBB4ERBB3LCK
Hydrochloric Acid SCHEMBL3505003 0.78 EGFR (0.66) EGFRERBB2ERBB4ERBB3LCK
SCHEMBL3506986 0.78 EGFR (0.61) EGFRERBB2ERBB4ERBB3
Hydrochloric Acid SCHEMBL3506629 0.78 EGFR (0.50) EGFRERBB2ERBB4ERBB3LCK
SCHEMBL3506229 0.76 EGFR (1.00) EGFRERBB2ERBB4ERBB3LCK
SCHEMBL3510356 0.75 EGFR (0.77) EGFRERBB2ERBB4ERBB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957495-A1 FUSED HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-08-20 EP claimed
WO-2007064045-A1 FUSED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-06-07 WO claimed